Follow The Money: Drugmakers Deploy Political Cash As Prices And Anger Mount
Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.
The independent source for health policy research, polling, and news.
521 - 540 of 959 Results
Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.
Experts say that costs may rise for some enrollees, but rates have been largely stable for most.
New federal rules requiring current information apply to insurers selling plans on healthcare.gov and the private policies that are an alternative to Medicare.
Insurers claim the cuts are deeper and are campaigning to stop them, saying they will hurt seniors.
The ratings, posted on Medicare’s website Thursday, rank hospitals based on patient reviews.
In 2015, some seniors enrolled in Medicare Advantage plans will be allowed to switch if they lose their doctors.
But it could take years to achieve coverage for everyone — if it happens at all.
UnitedHealthcare will appeal a federal judge's order temporarily blocking the insurer from dropping Connecticut providers, while doctors' groups in Ohio and New York look at bringing similar lawsuits.
In California, the vast majority of people renewing health insurance coverage in the state’s exchange did not switch health plans, and instead are sticking with the one they selected last year.
The insurer has been notifying members about the network changes as the Dec. 7 deadline for choosing coverage for next year quickly approaches.
House Republicans’ latest plan to repeal Obamacare would give states flexibility in managing their Medicaid programs, but also some difficult decisions to make.
Amid an uproar over high drug prices, three GOP senators are asking the Government Accountability Office to investigate whether the Orphan Drug Act is being abused.
Sens. Orrin Hatch and Richard Burr join with Rep. Fred Upton to renew a proposal to repeal the health law but preserve some tax credits for insurance and cuts to some Medicare providers.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
From Medicaid funding to paying for over-the-counter drugs, the legislation offered by House Republicans offers a far different pathway to coverage than Obamacare.
As part of their effort to improve quality while cutting costs, federal officials announced Monday that they want programs such as accountable care organizations and bundled care to account for 50 percent of traditional Medicare spending by the end of 2018.
Though not a part of the health law’s open enrollment period, Medicare’s enrollment period runs during some of the same time period. Changes to Medicare advantage and the so-called Medicare prescription drug “doughnut hole” are taking center stage.
The report credits slower growth in spending for private health insurance, Medicare, hospitals, physicians and clinical services.
Federal officials handle most of the requests in 2014 from beneficiaries seeking a hearing before a judge and cut into the heavy backlog. But cases from hospitals, doctors and other providers are still on hold.
© 2026 KFF